Gastric Ulcer vs Duodenal Ulcer: How to Tell Them Apart
Both are peptic ulcers—mucosal defects extending through the muscularis mucosae—driven by the same core insults (H. pylori, NSAIDs) when attack overwhelms mucosal defense. The axis that separates them is the pain-food relationship and the underlying acid/H. pylori pattern: gastric ulcers hurt with food and carry cancer risk, while duodenal ulcers are relieved by food and are rarely malignant.
How to tell them apart
| Feature | Gastric ulcer | Duodenal ulcer |
|---|---|---|
| Pain and food timing | Pain occurs with food—eating stimulates acid that directly contacts the ulcerated gastric mucosa | Pain 2–3 hours after meals and nocturnal; food buffers acid and relieves the pain |
| H. pylori infection pattern | Corpus-predominant infection damaging the acid-producing body/fundus | Antral-predominant infection that destroys D cells and their somatostatin |
| Acid physiology | Acid-low: parietal cell destruction causes hypochlorhydria | Acid-high: loss of somatostatin inhibition causes hypergastrinemia and increased acid output |
| Malignancy risk | Cancer risk is real—drives the metaplasia–dysplasia–adenocarcinoma sequence; always biopsy | Rarely malignant |
| Weight loss | Weight loss is a notable feature | Weight loss is not characteristic (and is an alarm symptom if present) |
| Classic bleeding vessel by location | Ulcers on the lesser curvature can erode into the left gastric artery | Posterior ulcers can erode into the gastroduodenal artery, the most common source of massive UGI bleeding; anterior ulcers tend to perforate |
| Acid-suppression duration | PPI for 4–8 weeks, continued until healing is confirmed | PPI for 4 weeks, continued until the patient is symptom-free |
| Follow-up endoscopy | Repeat endoscopy after treatment to confirm healing and exclude malignancy | Routine repeat endoscopy to confirm healing is not required |
The reasoning
Anchor on the pain-food relationship: pain worsened by eating with weight loss points to a gastric ulcer, while pain 2–3 hours after meals or at night that is relieved by eating points to a duodenal ulcer. This maps onto acid physiology—duodenal ulcers arise from antral-predominant H. pylori causing hypergastrinemia and high acid output, whereas gastric ulcers arise from corpus-predominant infection with hypochlorhydria and the precancerous metaplasia pathway. Because a gastric ulcer can be malignant, it must always be biopsied and re-scoped to confirm healing; a duodenal ulcer, rarely malignant, can be treated and followed by symptom resolution. When an ulcer bleeds or perforates, let anatomy arbitrate the culprit: posterior duodenal ulcer bleeding from the gastroduodenal artery versus lesser-curve gastric ulcer bleeding from the left gastric artery.
Key tests
- Upper endoscopy with biopsy: for a gastric ulcer, take multiple biopsies from the ulcer margin (4–6) plus random antral and corpus biopsies, and repeat endoscopy to confirm healing; a duodenal ulcer rarely requires biopsy because it is seldom malignant.
- H. pylori testing (urea breath test or stool antigen, not serology): positive in both, but reflects a corpus-predominant pattern in gastric ulcer and an antral-predominant pattern in duodenal ulcer; hold PPIs for 2 weeks and antibiotics/bismuth for 4 weeks to avoid false negatives, and always confirm eradication 4+ weeks after therapy.
- Endoscopy for alarm features (bleeding, weight loss, persistent vomiting, dysphagia, age >55 with new dyspepsia): mandatory for gastric ulcers to rule out cancer; used in duodenal ulcers mainly when patients fail empiric therapy or develop alarm symptoms.
What they share
- Epigastric pain that is burning, gnawing, or hunger-like
- Relief with antacids and worsening with coffee, alcohol, and smoking
- Caused by H. pylori and/or NSAID use—every patient with PUD should be tested for H. pylori
- Can present atypically or remain asymptomatic until a complication (especially in the elderly and NSAID users)
- Hemorrhage is the most common complication (hematemesis, melena, hemodynamic instability)
- Treated with PPI acid suppression, H. pylori eradication, and removal of offending agents such as NSAIDs
Pitfalls
- Treating a gastric ulcer as benign without biopsy—cancer can masquerade as an ulcer, so always biopsy the margins and confirm healing.
- Ordering H. pylori breath or stool tests while the patient is on a PPI, bismuth, or antibiotics, producing false negatives—hold PPIs for 2 weeks and antibiotics/bismuth for 4 weeks.
- Assuming ulcers are always symptomatic; elderly patients and NSAID users may be asymptomatic until they present with a complication such as bleeding.
- Forgetting to confirm H. pylori eradication after therapy—treatment failure is common.
- Overlooking Zollinger-Ellison syndrome in refractory, multiple, or atypically located ulcers.
- Misreading complication risk by location—posterior duodenal ulcers bleed (gastroduodenal artery) whereas anterior duodenal ulcers tend to perforate.
Practice this the way the exam tests it — on branching cases where your decisions shape the patient.